Harry Rek

T: +31 70 376 06 54
M: +31 6 53 31 31 18
E: harry.rek@barentskrans.nl
View Harry Rek on LinkedIn

Harry Rek (1961) started his career as a lawyer in 1985 and was a partner in large Dutch and international law firms. Since 1 January 2014 he is a partner in the corporate practice of BarentsKrans. Harry has extensive experience with complex international transactions, often a combination of M&A and strategic commercial contracts. He led transactions in the Dutch telecoms, energy and waste management markets, and in and outside the Netherlands for IT and media companies, as well as hotel transactions. In the Dutch market he is also active in private equity transactions, from small investments in innovative companies to complex exit transactions. He also advises start-ups and young businesses on their structure and commercial contracts, and more established companies on their corporate governance. Clients praise him for his practical “hands on” attitude, combined with sound business judgment and a good understanding of the commercial objectives of his clients.

Selected directory listings

Harry Rek is especially skilled.’ – Legal 500, 2022

‘Harry Rek, senior partner, is especially experienced and has top rate people skills in guiding his client to sensible decisions. Provides specific guidance as to what clients should do rather than merely pointing out options and risks, hence providing true advice.’ – Legal 500, 2021

‘Under the leadership of Harry Rek, BarentsKrans handles domestic private equity and venture capital work for clients in the technology, biotechnology, safety and security industries.’ – Legal 500, 2021

Recently from this specialist

BarentsKrans has advised Axion BioSystems on its acquisition of CytoSMART

Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, announces the acquisition of the Netherlands-based CytoSMART Technologies—an innovator in kinetic live-cell imaging analysis. The collaboration positions Axion for significant expansion in the fields of stem cell research, immuno-oncology, cell-based therapies, and drug discovery. “Since Axion BioSystems’ inception, our focus has
Read more ›

BarentsKrans assisted VanderSat Holding on the sale of VanderSat to Planet Labs

BarentsKrans advised VanderSat Holding on the sale of specialized Dutch software developer VanderSat to Planet Labs, an American satellite company based in San Francisco. The transaction closed on 13 December 2021. Through this sale, VanderSat will be able to broaden its network and possibilities to use its science and technology on an even larger scale.
Read more ›
More from this specialist